Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40
書誌事項
- 公開日
- 2016-01
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- http://www.elsevier.com/open-access/userlicense/1.0/
- DOI
-
- 10.1016/j.clim.2015.11.002
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- Clinical Immunology
-
Clinical Immunology 162 37-44, 2016-01
Elsevier BV